In inflammatory bowel disease the differential diagnosis as well as the evaluation of specific morphological, chemical, and histochemical indices still present serious difficulties. The recent proposal by Falchuk et al. (1975a) that changes in the concentration of a specific serum marker-namely, lysozyme (LZM)-might be an aid in the differential diagnosis of uncomplicated ulcerative colitis and active Crohn's disease has been questioned by a number of authors (Dronfield and Langman, 1975; Peeters et al., 1975; Pounder et al., 1975; Pruzanski and Marcon, 1975; Hylander et al., 1976; Johansson and Ursing, 1976) . However, the determination of the serum concentration of LZM has been reported to be of value in estimating disease activity in Crohn's disease (Falchuk et al., 1975b ). An increased LZM content has been observed in the colonic exudates and stools of patients with ulcerative colitis (Hiatt et al., 1952) . This variation in the serum and stool LZM concentration has been attributed to the increased number of LZM-containing cells in the inflammatory intestinal lesions. Recently, Mason and Taylor (1975) Received for publication 19 November 1976 with immunohistochemical techniques, the distribution of LZM-containing cells in the intestinal lesions of patients with ulcerative colitis and Crohn's disease.
Methods
Fifteen patients with ulcerative colitis, seven patients with Crohn's disease, and 24 control patients were studied (Table) . Intestinal biopsies were taken either at the surgical resection of affected segments of the small or large bowel. The diagnosis in these cases was based on typical clinical, radiological, and morphological findings. Biopsies were also obtained from the normal small and large intestines of control patients operated on for a disease other than an acute or chronic inflammatory bowel disease, most often for a localised carcinoma of the colon. The biopsy specimens, none larger than 2 mm in thickness, were fixed in 1.5 % aqueous glutaraldehyde (TAAB Laboratories, Reading) for 90 minutes, dehydrated in absolute ethanol and xylene, and then embedded in paraffin. Paraffin sections were cut to 6 um in thickness, deparaffinised and rehydrated, and then washed in 0-01 M phosphate-buffered saline (PBS), pH 7-2, twice for five minutes each time. The presence of LZM in tissues was demonstrated with an immunoglobulin-enzyme bridge method (Mason et al., 1969) described in detail elsewhere (Klockars and Reitamo, 1975 Graham and Karnovsky (1966) and then counterstained with cresyl echt violet. To abolish the intrinsic peroxidase activity of granulocytes and erythrocytes, sections were pretreated with methanol-H202 (Streefkerk, 1972) . For control of the specificity of the reaction between tissue LZM and the primary antiserumthat is, rabbit antihuman LZM-this antiserum was replaced by a rabbit antiserum raised against hen egg white LZM, known to be immunologically different from its human counterpart.
Results

CONTROL SUBJECTS
In the normal ileum LZM was present only in the Paneth cells of the intestinal crypts and in granulocytes and macrophages in the intestinal lamina propria. In normal colon no LZM was detected in surface epithelial cells or in mucous crypt cells, nor was LZM present in the lamina propria except in a few granulocytes. Normal rectum contained no LZM-positive cells (Table) . (Table) . This staining was most often diffuse but in a few cells granular (Fig. 2) and in some colonic crypt cells the cytoplasmic morphology and LZM staining was identical with that in the ileal Paneth cells (Fig. 2) . (Fig. 3 ). Most cells of epitheloid A granulomas stained intensely for LZM (Fig. 4) . In one patient some mucosal crypt cells stained for LZM (Table) . Lymphoctyes, plasma cells, and fibrous tissue showed no LZM staining. In normal conditions about 80% of the total pool of LZM is thought to be of granulocyte origin, (Hansen, 1974) , and in some tissues the concentra- . . . . . . . . ; tion of LZM is related to the number of granulos cytes, monocytes, and macrophages (Lippman and Finch, 1972; Klockars and Reitamo, 1975) . In both ulcerative colitis and Crohn's disease, affected lesions of the intestine contained large numbers of LZMpositive cells, which provides at least one explanation for raised concentrations of plasma LZM in patients with these disorders (Kane et al., 1974; Dronfield .....tandlLangman, 1975; Falchuk et al., 1975; Pounder, et al., 1975) . That both the total vitamin B12-binding ....... capacity and the LZM activity of serum are increased in these disorders might indicate that the pool of granulocytes is enlarged and their turnover accele-0 _ |1rated (Kane et al., 1974) .
In many patients with ulcerative colitis and in one patient with Crohn's disease, the presence of LZM in occasional gland cells, although not contributory to the raised levels of serum LZM, contrasts with the absence of LZM of normal colonic mucosa. The LZM in these cells might be a consequence of (1) colitis (Gad, 1969) might eliminate a possible block-380 M. Klockars, S. Reitamo, J. J. Reitamo, and C. Moller ing effect of the acidic mucosubstances on the antigenic determinants critical for the detection of LZM with the present method. The presence of LZM in secretory cells in normal organs has been observed to be associated with the presence of neutral mucosubstances (Klockars and Reitamo, 1975) . The occurrence of typical LZM-positive Paneth cells in mucosal glands adjacent to mucosal crypt cells with positive cytoplasmic granular LZM staining raises the question of whether a transition occurs between mucous gland cells and Paneth cells (Watson and Roy, 1960; Paterson and Watson, 1961; Lewin, 1969) . Whereas the origin and 'stem cell' of Paneth cells is still unknown, the results of the present study support the possibility that glandular cells of the mucosa are transformed into Paneth cells. Our preliminary observations show that metaplastic Paneth cells associated with gastric carcinomas also retain their capacity to elaborate LZM.
In patients with Crohn's disease the epitheloid cells of intestinal granulomas are an end stage in the transformation of monocytes and macrophages. Morphological (Sutton and Weiss, 1966) and biochemical studies (Cohn and Benson, 1965) show that both the number oflysosomes and the concentration of lysosomal enzymes, including LZM, increase during the course of this transformation. Similarly, strong LZM activity has been observed in epitheloid cell granulomas in sarcoidosis and in Kveimpositive subcutaneous nodules (Mason and Taylor, 1975) .
Although the findingspresented heredo not provide any conclusive information about possible differences in serum concentrations of LZM in Crohn's disease and ulcerative colitis (Falchuk et al., 1975a) , it is possible that the fate of LZM-containing inflammatory cells and their enzymic content might differ in these diseases. Fixed mononuclear phagocytes may lose their enzymic content into the circulation, whereas the granulocytes in ulcerative colitis might ultimately reach the colonic lumen by diapedesis (Anthonisen and Riis, 1962) .
In the absence of any known substrate for LZM in mammalian cells, the physiological consequences of the presence of high local concentrations of LZM might be related to the effects of LZM on cell membranes (Osserman et al., 1973) , to its antibacterial effects (Chipman and Sharon, 1969) , to its enhancing effect on phagocytosis (Klockars and Roberts, 1976) , or to its tendency to form complexes with a variety of anionic molecules (Imoto et al., 1971) . 
